Stem cell therapy for ischemic heart disease

Antioxidants and Redox Signaling

Volumn 13, Issue 12, 2010, Pages 1879-1897

  Jameel, Mohammad Nurulqadr ^a   Zhang, Jianyi ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CELL REGENERATION; CELL TYPE; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

HUMANS; MYOCARDIAL ISCHEMIA; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

ANIMALIA;

EID: 78149301243     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3434     Document Type: Review

References (161)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boue S, and Izpisua Belmonte JC. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284, 2008.
2. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, Li RA, O'Rourke B, and Marban E. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 97: 159-167, 2005.
3. Alhadlaq A and Mao JJ. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13: 436-448, 2004.
4. Anderson D, Self T, Mellor IR, Goh G, Hill SJ, and Denning C. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 15: 2027-2036, 2007.
5. Anversa P and Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 83: 1-14, 1998.
6. Anversa P and Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 415: 240-243, 2002.
7. Anversa P, Sussman MA, and Bolli R. Molecular genetic advances in cardiovascular medicine: focus on the myo-cyte. Circulation 109: 2832-2838, 2004.
8. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, and Yamanaka S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321: 699-702, 2008.
9. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for an-giogenesis. Science 275: 964-967, 1997.
10. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weiss-man IL, and Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668-673, 2004.
11. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, and Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863-868, 2003.
12. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIn-tosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, and Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48, 2002.
13. Bearzi C, Muller P, Amano K, Tang X-L, Loredo M, Mosna F, Gatti A, Esposito G, Leri A, Kajsutra J, Anversa P, Ri-moldi O, and Bolli R. Identification and characterization of cardiac stem cells in the pig heart. Circulation 114: II-125, 2006.
14. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, D'Alessan-dro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, and Anversa P. Human cardiac stem cells. Proc Natl Acad Sci USA 104: 14068-14073, 2007.
15. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776, 2003.
16. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, and Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. New Engl J Med 344: 1750-1757, 2001.
17. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, and Frisen J. Evidence for cardio-myocyte renewal in humans. Science 324: 98-102, 2009.
18. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, Freilinger M, Hoger H, Elbe-Burger A, and Wachtler F. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol 199: 391-396, 1999.
19. Caplan AI. Mesenchymal stem cells. J Orthop Res 9: 641-650, 1991.
20. Cerisoli F, Chimenti I, Gaetani R, Barile L, and Frati G. Kit-positive cardiac stem cells (CSCs) can be generated in damaged heart from bone marrow-derived cells. Circulation 114: II-164, 2006.
21. Chen X, Wilson RM, Kubo H, Berretta RM, Harris DM, Zhang X, Jaleel N, MacDonnell SM, Bearzi C, Tillmanns J, Trofimova I, Hosoda T, Mosna F, Cribbs L, Leri A, Kajstura J, Anversa P, and Houser SR. Adolescent feline heart contains a population of small, proliferative ventricular myo-cytes with immature physiological properties. Circ Res 100: 536-544, 2007.
22. Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F, Nadal-Ginard B, Frustaci A, Leri A, Maseri A, and Anversa P. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 93: 604-613, 2003.
23. Cowan CA, Atienza J, Melton DA, and Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309: 1369-1373, 2005.
24. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, and Kloner RA. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 112: 214-223, 2005.
25. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, Rastaldo R, Torella D, Tang XL, Rezazadeh A, Kajstura J, Leri A, Hunt G, Varma J, Prabhu SD, Anversa P, and Bolli R. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 102: 3766-3771, 2005.
26. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, and Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843, 2002.
27. Doetschman TC, Eistetter H, Katz M, Schmidt W, and Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87: 27-45, 1985.
28. Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, and Field LJ. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58: 336-350, 2003.
29. Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S, Chen K, Li Y, Liu X, Xu J, Zhang S, Li F, He W, Labuda K, Song Y, Peterbauer A, Wolbank S, Redl H, Zhong M, Cai D, Zeng L, and Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6: 71-79, 2010.
30. Fukuda K. Molecular characterization of regenerated car-diomyocytes derived from adult mesenchymal stem cells. Congenital Anom 42: 1-9, 2002.
31. Fukuda K. Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant 32 Suppl 1: S25-S27, 2003.
32. Graichen R, Xu X, Braam SR, Balakrishnan T, Norfiza S, Sieh S, Soo SY, Tham SC, Mummery C, Colman A, Zwei-gerdt R, and Davidson BP. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76: 357-370, 2008.
33. Haider HK, Idris NM, Kim HW, Ahmed RP, Shujia J, and Ashraf M. MicroRNA-21 is a key determinant in IL11= STAT-3 anti-apoptotic signaling pathway in preconditioning of skeletal myoblasts. Cardiovasc Res 88: 168-178, 2010.
34. Hakuno D, Fukuda K, Makino S, Konishi F, Tomita Y, Manabe T, Suzuki Y, Umezawa A, and Ogawa S. Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation 105: 380-386, 2002.
35. Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, Yuasa S, Li W, Yamakawa H, Tanaka T, Onitsuka T, Shi-moji K, Ohno Y, Egashira T, Kaneda R, Murata M, Hidaka K, Morisaki T, Sasaki E, Suzuki T, Sano M, Makino S, Oi-kawa S, and Fukuda K. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7: 61-66, 2010.
36. Haynesworth SE, Baber MA, and Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13: 69-80, 1992.
37. He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E, White D, Taylor DA, Wang J, and Burkhoff D. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant 24: 1940-1949, 2005.
38. Hirata Y, Sata M, Motomura N, Takanashi M, Suematsu Y, Ono M, and Takamoto S. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Bio-chem Biophys Res Commun 327: 609-614, 2005.
39. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, and Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460: 1132-1135, 2009.
40. Hosoda T, Bearzi C, Amano S, Rota M, Valentini S, De-lucchi F, Tillmanns J, Nascimbene A, Angelis AD, Siggins RW, Zias E, Quaini F, Urbanek K, Leri A, Kajstura J, Bolli R, and Anversa P. Human cardiac progenitor cells regenerate cardiomyocytes and coronary vessels repairing the in-farcted myocardium. Circulation 114: II-51, 2006.
41. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, Robbins J, and Lee RT. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 13: 970-974, 2007.
42. Huber I, Itzhaki I, Caspi O, Arbel G, Tzukerman M, Gep-stein A, Habib M, Yankelson L, Kehat I, and Gepstein L. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J 21: 2551-2563, 2007.
43. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, and Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402, 2001.
44. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, Zawadzka A, Wetzel K, Sawyer DB, Colucci WS, Apstein CS, and Liao R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103: 1920-1927, 2001.
45. Jameel MN, Li Q, Mansoor A, Qiang X, Sarver A, Wang X, Swingen C, and Zhang J. Long term functional improvement and gene expression changes after bone marrow derived multipotent progenitor cell transplantation in myocardial infarction. Am J Physiol 298: H1348-H1356, 2010.
46. Johnston P, Sasano T, Mills K, Youssef A, Pittenger M, Lange R, and Marban E. Isolation, expansion and delivery of cardiac derived stem cells in a porcine model of myo-cardial infarction. Circulation 114: II-125, 2006.
47. Kajstura J, Urbanek K, Perl S, Hosoda T, Zheng H, Ogorek B, Ferreira-Martins J, Goichberg P, Rondon C, D'Amario D, Rota M, Del Monte F, Orlic D, Tisdale J, Leri A, and An-versa P. Cardiomyogenesis in the adult human heart. Circ Res 107: 305-315, 2010.
48. Kajstura J, Urbanek K, Rota M, Bearzi C, Hosoda T, Bolli R, Anversa P, and Leri A. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol 45: 505-513, 2008.
49. Kattman SJ, Huber TL, and Keller GM. Multipotent flk-1\+ cardiovascular progenitor cells give rise to the cardiomyo-cyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11: 723-732, 2006.
50. Kawai T, Takahashi T, Esaki M, Ushikoshi H, Nagano S, Fujiwara H, and Kosai K. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein2.Circ J 68: 691-702, 2004.
51. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, and Asahara T. Intramyocardial transplantation of autolo-gous endothelial progenitor cells for therapeutic neo-vascularization of myocardial ischemia. Circulation 107: 461-468, 2003.
52. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, and Gep-stein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of car-diomyocytes. J Clin Invest 108: 407-414, 2001.
53. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, and Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22: 1282-1289, 2004. (Pubitemid 39341201)
54. Kim BO, Tian H, Prasongsukarn K, Wu J, Angoulvant D, Wnendt S, Muhs A, Spitkovsky D, and Li RK. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112: I96-104, 2005.
55. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, Meyer J, Hubner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, and Scholer HR. Oct4-induced pluripotency in adult neural stem cells. Cell 136: 411-419, 2009.
56. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkh-off D, Wang J, Homma S, Edwards NM, and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001.
57. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Ca-plan AI, Colletti EJ, Almeida-Porada G, Muller HW, Zan-jani E, and Wernet P. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200: 123-135, 2004.
58. Koh GY, Klug MG, Soonpaa MH, and Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 92: 1548-1554, 1993.
59. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, Sasse P, Rubenchik O, Fries JW, Wenzel D, Geisen C, Xia Y, Lu Z, Duan Y, Kettenhofen R, Jovinge S, Bloch W, Bohlen H, Welz A, Hescheler J, Jacobsen SE, and Fleischmann BK. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 203: 2315-2327, 2006.
60. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, Ratajczak J, Rezzoug F, Ildstad ST, Bolli R, and Ra-tajczak MZ. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 95: 1191-1199, 2004.
61. Kuzmenkin A, Liang H, Xu G, Pfannkuche K, Eichhorn H, Fatima A, Luo H, Saric T, Wernig M, Jaenisch R, and He-scheler J. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J 23: 4168-4180, 2009.
62. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fu-gate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, and Murry CE. Cardiomyo-cytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25: 1015-1024, 2007.
63. Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, Police S, Muskheli V, and Murry CE. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167: 663-671, 2005.
64. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woo-dard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, and Chien KR. Postnatal isl1\+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653, 2005.
65. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, and Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31: 890-896, 2003.
66. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, and Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20, 2003.
67. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, and Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 100: 7808-7811, 2003.
68. Leri A, Kajstura J, and Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85: 1373-1416, 2005.
69. Lewis ID and Verfaillie CM. Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood. Exp Hematol 28: 1087-1095, 2000.
70. Lin Y, Weisdorf DJ, Solovey A, and Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77, 2000.
71. Linke A, Muller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, Castaldo C, Cascapera S, Bohm M, Quaini F, Urbanek K, Leri A, Hintze TH, Kajstura J, and Anversa P. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102: 8966-8971, 2005.
72. Liu J, Hu Q, Wang Z, Xu C, Wang X, Gong G, Mansoor A, Lee J, Hou M, Zeng L, Zhang JR, Jerosch-Herold M, Guo T, Bache RJ, and Zhang J. Autologous stem cell transplantation for myocardial repair. Am J Physiol 287: H501-H511, 2004.
73. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, and Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105: 2883-2888, 2008.
74. Ma N, Stamm C, Kaminski A, Li W, Kleine HD, Muller-Hilke B, Zhang L, Ladilov Y, Egger D, and Steinhoff G. Human cord blood cells induce angiogenesis following myocardial infarction in NOD=scid-mice. Cardiovasc Res 66: 45-54, 2005.
75. MacLellan WR and Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 62: 289-319, 2000.
76. Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh KR, and Mosca JD. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10: 228-241, 2003.
77. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, and Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705, 1999.
78. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, and Garry DJ. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 265: 262-275, 2004.
79. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, and Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res 105: 648-656, 2009.
80. Masuda H and Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Car-diovasc Res 58: 390-398, 2003.
81. Matsura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano M, Toko H, Akazawa H, Sato T, Nakaya H, Ka-sanuki H, and Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279: 11384-11391, 2004.
82. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, and Martin U. Generation of functional mu-rine cardiac myocytes from induced pluripotent stem cells. Circulation 118: 507-517, 2008.
83. Mayani H and Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem=progenitor cells. Stem Cells 16: 153-165, 1998.
84. Melton C, Judson RL, and Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463: 621-626, 2010.
85. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, and Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95: 911-921, 2004.
86. Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, and Xiao YF. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92: 288-296, 2002.
87. Minguell JJ, Erices A, and Conget P. Mesenchymal stem cells. Exp Biol Med 226: 507-520, 2001.
88. Moretti A, Bellin M, Jung CB, Thies TM, Takashima Y, Bernshausen A, Schiemann M, Fischer S, Moosmang S, Smith AG, Lam JT, and Laugwitz KL. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1\+ cardiovascular progenitors. FASEB J 2009.
89. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, and Chien KR. Multipotent embryonic isl1\+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127: 1151-1165, 2006.
90. Mouquet F, Pfister O, Jain M, Oikonomopoulos A, Ngoy S, Summer R, Fine A, and Liao R. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res 97: 1090-1092, 2005.
91. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, and Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105: 1527-1536, 2000.
92. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Naka-jima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, and Field LJ. Haematopoietic stem cells do not transdiffer-entiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668, 2004.
93. Nadal-Ginard B, Kajstura J, Leri A, and Anversa P. Myo-cyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92: 139-150, 2003.
94. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichi-saka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, and Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Bio-technol 26: 101-106, 2008.
95. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Mat-suoka S, Yamanaka S, and Yamashita JK. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118: 498-506, 2008.
96. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, and Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120: 408-416, 2009.
97. Niagara MI, Haider H, Jiang S, and Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100: 545-555, 2007.
98. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Reinecke H, and Murry CE. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21: 1345-1357, 2007.
99. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, and Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313-12318, 2003.
100. Okita K, Ichisaka T, and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317, 2007.
101. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, and Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953, 2008.
102. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001.
103. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shima-mura A, Lensch MW, Cowan C, Hochedlinger K, and Daley GQ. Disease-specific induced pluripotent stem cells. Cell 134: 877-886, 2008.
104. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, and Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146, 2008.
105. Passier R, Oostwaard DW, Snapper J, Kloots J, Hassink RJ, Kuijk E, Roelen B, de la Riviere AB, and Mummery C. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23: 772-780, 2005.
106. Pfannkuche K, Liang H, Hannes T, Xi J, Fatima A, Nguemo F, Matzkies M, Wernig M, Jaenisch R, Pillekamp F, Halbach M, Schunkert H, Saric T, Hescheler J, and Reppel M. Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell Physiol Biochem 24: 73-86, 2009.
107. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A, Colucci WS, and Liao R. CD31\-but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97: 52-61, 2005.
108. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, and Prockop DJ. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436, 1999.
109. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, and Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
110. Pittenger MF and Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20, 2004.
111. Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276: 71-74, 1997.
112. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, and Anversa P. Chi-merism of the transplanted heart. New Engl J Med 346: 5-15, 2002.
113. Reinecke H, MacDonald GH, Hauschka SD, and Murry CE. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 149: 731-740, 2000.
114. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breit-bach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, and Fleischmann BK. Engraftment of con-nexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450: 819-824, 2007.
115. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas ME, Gonzalez A, Rizzi R, Small N, Muraski J, Alvarez R, Chen X, Urbanek K, Bolli R, Houser SR, Leri A, Sussman MA, and Anversa P. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA 104: 17783-17788, 2007.
116. Rubart M and Field LJ. Cardiac regeneration: repopulating the heart. Annu Rev Physiol 68: 29-49, 2006.
117. Ryan JM, Barry FP, Murphy JM, and Mahon BP. Me-senchymal stem cells avoid allogeneic rejection. J Inflamm 2: 8, 2005.
118. Satin J, Itzhaki I, Rapoport S, Schroder EA, Izu L, Arbel G, Beyar R, Balke CW, Schiller J, and Gepstein L. Calcium handling in human embryonic stem cell-derived cardio-myocytes. Stem Cells 26: 1961-1972, 2008.
119. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, and Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3: 568-574, 2008.
120. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, and Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156, 2005.
121. Singla DK, Hacker TA, Ma L, Douglas PS, Sullivan R, Lyons GE, and Kamp TJ. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 40: 195-200, 2006.
122. Singla DK, Lyons GE, and Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol 293: H1308-H1314, 2007.
123. Singla DK and McDonald DE. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol 293: H1590-H1595, 2007.
124. Singla DK, Singla RD, and McDonald DE. Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K=Akt but not ERK pathway. Am J Physiol 295: H907-H913, 2008.
125. Singla DK and Sun B. Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun 332: 135-141, 2005.
126. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, and Marban E. Re generative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115: 896-908, 2007.
127. Soonpaa MH and Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 83: 15-26, 1998.
128. Stadtfeld M, Brennand K, and Hochedlinger K. Repro-gramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18: 890-894, 2008.
129. Stadtfeld M, Nagaya M, Utikal J, Weir G, and Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 322: 945-949, 2008.
130. Sussman MA and Anversa P. Myocardial aging and senescence: where have the stem cells gone? Annu Rev Physiol 66: 29-48, 2004.
131. Suzuki G, Iyer V, Cimato T, and Canty JM Jr. Pravastatin improves function in hibernating myocardium by mobilizing CD133\+ and cKit\+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ Res 104: 255-264, 210p following 264, 2009.
132. Tada M, Takahama Y, Abe K, Nakatsuji N, and Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11: 1553-1558, 2001.
133. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872, 2007.
134. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006.
135. Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, Dawn B, Hunt G, Leri A, Kajstura J, Tiwari S, Shirk G, Anversa P, and Bolli R. In-tracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121: 293-305, 2010.
136. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, and Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933, 1998.
137. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, and Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.
138. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, and Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: II247-II256, 1999. (Pubitemid 29523543)
139. Tomita S, Nakatani T, Fukuhara S, Morisaki T, Yutani C, and Kitamura S. Bone marrow stromal cells contract synchronously with cardiomyocytes in a coculture system. Jpn J Thorac Cardiovasc Surg 50: 321-324, 2002.
140. Torella D, Elliso GM, Karakikes I, Galuppo V, Serio DD, Onorati F, Mastroroberto P, Renzulli A, Indolfi C, and Nadal-Ginard B. Biological properties and regenerative potential, in vitro and in vivo, of human cardiac stem cells isolated from each of the four chambers of the adult human heart. Circulation 114: II-87, 2006.
141. Tse WT, Pendleton JD, Beyer WM, Egalka MC, and Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397, 2003.
142. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana F, Nurzynska D, Torella D, Rotatori F, Rastaldo R, Musso E, Quaini F, Leri A, Kajstura J, and Anversa P. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97: 663-673, 2005.
143. Urbanek K, Torella D, Sheikh F, De Angelis A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP, Quaini F, Bolli R, Leri A, Kajstura J, and Anversa P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 102: 8692-8697, 2005.
144. Wang JS, Shum-Tim D, Chedrawy E, and Chiu RC. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 122: 699-705, 2001.
145. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, and Zhang J. The role of the sca-1\+=CD31-cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 24: 1779-1788, 2006.
146. Wang X, Jameel MN, Li Q, Mansoor A, Qiang X, Swingen C, Panetta C, and Zhang J. Stem cells for myocardial repair with use of a transarterial catheter. Circulation 120: S238-S246, 2009.
147. Weir RA and McMurray JJ. Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Curr Heart Fail Rep 3: 175-180, 2006.
148. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, and Jaenisch R. In vitro re-programming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324, 2007.
149. Wilmut I, Schnieke AE, McWhir J, Kind AJ, and Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-813, 1997.
150. Wobus AM, Guan K, Yang HT, and Boheler KR. Embryonic stem cells as a model to study cardiac, skeletal muscle, and vascular smooth muscle cell differentiation. Methods Mol Biol 185: 127-156, 2002.
151. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM, and Orkin SH. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127: 1137-1150, 2006.
152. Xu C, Police S, Rao N, and Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91: 501-508, 2002.
153. Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, Tomaselli GF, and Li RA. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111: 11-20, 2005.
154. Yamanaka S. A fresh look at iPS cells. Cell 137: 13-17, 2009.
155. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, and Keller GM. Human cardiovascular progenitor cells develop from a KDR\+ embryonic-stem-cell-derived population. Nature 453: 524-528, 2008.
156. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, and Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
157. Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, and Zhang J. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115: 1866-1875, 2007.
158. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, and Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-e41, 2009.
159. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Scholer HR, Duan L, and Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384, 2009.
160. Zimmet JM and Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol 100: 471-481, 2005.
161. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, and Gepstein L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120: 1513-1523, 2009.